Clinical Trials Logo

Circadian Rhythm clinical trials

View clinical trials related to Circadian Rhythm.

Filter by:

NCT ID: NCT02642640 Completed - Circadian Rhythm Clinical Trials

Interaction of Melatonin and MTNR1B Genotype on Glucose Control - Study 1

Start date: November 2016
Phase: N/A
Study type: Interventional

This project aims to test the impact of melatonin and MTNR1B variation on regulation glucose regulation in a highly controlled in-laboratory setting and ex vivo in pancreatic islets.

NCT ID: NCT02604875 Completed - Circadian Rhythm Clinical Trials

The Circadian Rhythm of Copeptin

Co-Rhythm
Start date: November 2015
Phase: N/A
Study type: Observational

The circadian rhythm of copeptin will be examined in healthy subjects.

NCT ID: NCT01900639 Completed - Clinical trials for Cardiovascular Diseases

Aspirin AM or PM: Effect on Circadian Rhythm of Platelet Reactivity

Start date: July 2013
Phase: Phase 4
Study type: Interventional

Low-dose aspirin is a cornerstone in the secondary prevention of cardiovascular disease (CVD) and is usually taken on awakening, although evidence regarding optimal time of intake is lacking. Platelet reactivity follows a circadian rhythm, with a peak in the morning, contributing to the morning peak of cardiovascular disease. Due to its short half life, aspirin only inhibits platelets which are present at the time of intake. Thus, the timing of aspirin intake may influence its inhibitory effect on platelets and intake of aspirin at bedtime may attenuate the morning peak of platelet reactivity. The time-dependent effect of aspirin on circadian rhythm of platelet function has never been studied before. We hypothesize that aspirin intake at bedtime compared with intake on awakening results in a reduction of the morning peak in platelet reactivity.

NCT ID: NCT00945230 Completed - Pain Clinical Trials

Actigraphic Measurement of a Neurosurgical Procedure

Start date: March 2009
Phase: N/A
Study type: Interventional

The study examines and illustrates the utility of utilizing actigraphic measurements to assess treatment response.

NCT ID: NCT00707226 Completed - Clinical trials for Glaucoma, Open-Angle

Circadian Variations in Ocular Blood Flow in Glaucomatous and Normal Eyes

Start date: November 2000
Phase: N/A
Study type: Observational

After focusing many years only on intraocular pressure (IOP) as the primary risk factor, recently the impact of ocular blood flow is getting more consideration for the pathophysiology of glaucoma. The circadian change of intraocular pressure (IOP) is well investigated, but diurnal variations in ocular blood flow are yet to be evaluated, especially in glaucomatous eyes. This study is performed to investigate circadian variation of ocular blood flow assessed by laser interferometric fundus pulsation amplitude (FPA) and laser Doppler flowmetry (LDF) in glaucomatous eyes during topical antiglaucoma therapy at 8:00, 12:00, 17:00 and 21:00, to compare these circadian variation of ocular blood flow in glaucomatous eyes with variations in healthy eyes and to relate blood flow variations with IOP variations.

NCT ID: NCT00607204 Completed - Sleep Clinical Trials

Examining the Biological Factors That Affect Sleep Duration

Start date: October 2005
Phase: N/A
Study type: Observational

Sleep is necessary for healthy functioning, and people who sleep too little or too much may have an increased risk of developing health problems. This study will examine people who regularly sleep for short or long amounts of time to understand the biological factors that determine how much sleep a person needs.

NCT ID: NCT00456222 Completed - Sleep Clinical Trials

Impact of Sleep Disruption on the Menstrual Cycle

Start date: June 2003
Phase: N/A
Study type: Observational

The purpose of this study is to investigate whether sleep disruption affects menstrual cycle timing

NCT ID: NCT00200863 Completed - Healthy Clinical Trials

Effects of Different Colors of Light on Human Physiology

Start date: April 2005
Phase: N/A
Study type: Interventional

This study will determine which color of light is most effective in stimulating a range of biological functions in humans including activation of sleep-wake regulatory system (alertness, performance, microsleeps, brain activity), activation of the nervous system (heart rate, temperature, blood pressure, breathing rate), and shifting the timing of the internal 24-hour (circadian) pacemaker.

NCT ID: NCT00001285 Completed - Bipolar Disorder Clinical Trials

Effects of Sex Hormones on Circadian Rhythm in Men and Women

Start date: August 1991
Phase: N/A
Study type: Observational

For many years researchers have been trying to better understand the regulation of sleep and activity by studying circadian (daily) rhythms of human beings. It appears that the hormones estrogen, progesterone, and testosterone play a role in the regulation of circadian rhythm in animals. Researchers believe these hormones may also play a similar role in the regulation of human circadian rhythms. Little research has been conducted on how these hormones affect human circadian rhythms. This study is designed to learn more about how specific hormones influence men and women's daily rhythms. This study will use women from another research study being conducted at the NIMH called, "The central nervous system effects of pharmacologically induced hypogonadotropic hypogonadism with and without estrogen and progesterone". Male subjects will be recruited from another NIMH study called, "The central nervous system effects of pharmacologically induced hypogonadotropic hypogonadism with and without testosterone replacement". In order to test the possibility that gonadal steroids (estrogen, progesterone, and testosterone) change circadian rhythms and the sleep-wake cycle in humans, participants will undergo chronobiologic evaluations. The chronobiologic evaluations will look at sleep and rest periods, activity as measured by a wrist monitor, and 24 hour inpatient electroencephalograph (EEG), rectal temperature, and melatonin monitoring.